THE PRIMER
SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share
Get Ahead With Life Science Executive Certifications
Working professionals in exciting, dynamic industries like biotech, pharma, and med device have much to gain by keeping up with the latest technologies, best practices, and scientific techniques.
Your Competitive Edge
Continuing professional education (CPE) courses offer an edge, enabling life science financial professionals to keep pace with innovations, advance their careers, and sharpen in-demand skills.
Cell Line Madness
The production of biologics depends on cell lines—living factories that originate from a primary culture and have the remarkable ability to grow and multiply.
Stump the Clumps: Treating Amyloidosis
Amyloid is a protein that builds up in the liver, spleen, and other tissues. When amyloid folds incorrectly, the protein sticks together and forms fibrous deposits in and around cells, causing amyloidosis. Fortunately, affected patients are benefitting from new, cutting-edge treatment options.
Silencing Disease: Unveiling the Potential of ASO’s
Antisense oligonucleotide (ASO) technology revolutionizes disease treatment by specifically targeting and modifying RNA. This therapeutic class is rapidly gaining traction due to its precision in targeting proteins that are inaccessible to traditional treatments.
Special Delivery: Gene Therapy Vectors
There are two broad approaches to gene therapy treatment, in vivo and ex vivo, and each relies on a different gene vector to get the job done. Let’s take a closer look.
Branches of Biotechnology
Biotechnology uses living organisms or their components to address many of our largest global challenges in healthcare, agriculture, the environment, and industry.
Biotech vs. Biopharma: Understanding the Differences
Biotechnology, pharmaceuticals, and biopharmaceuticals: these terms and abbreviations (biotech, pharma, and biopharma, respectively) are everywhere in today’s lexicon. However, which aspect of research does each term refer to, and more importantly, how are they different?
Pathways to Progress: FDA Fast Tracks Huntington’s Treatments
The biotech sector is witnessing significant developments in the battle against Huntington’s Disease (HD).
AI Boosts Biologic Breakthroughs
The biopharmaceutical landscape is rapidly expanding at a CAGR of 12.5%, with its market value set to rise from USD 333.09 billion in 2022 to USD 856.1 billion by 2030.
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.